All Stories

  1. Pathophysiology of AV Fistula Maturation and Non-Maturation
  2. Clinical relevance of the left brachiocephalic vein anatomy for vascular access in dialysis patients
  3. Charcoal for the management of pruritus and uremic toxins in patients with chronic kidney disease
  4. Vitamin K effects in human health: new insights beyond bone and cardiovascular health
  5. Phosphate and bone fracture risk in chronic kidney disease patients
  6. Increased Risk of Bone Fractures in Hemodialysis Patients Treated with Proton Pump Inhibitors in Real World: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)
  7. Dietary Fiber and Gut Microbiota in Renal Diets
  8. Summary of the International Conference on Onco-Nephrology: an emerging field in medicine
  9. Rituximab as Maintenance Treatment for Systemic Lupus Erythematosus: A Multicenter Observational Study of 147 Patients
  10. Endorsement and evaluation of dialysis access guidelines from the standpoint of the Vascular Access Society
  11. Update on ANCA-associated vasculitis: from biomarkers to therapy
  12. Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
  13. Dietary Fiber and Gut Microbiota in Renal Diets
  14. Clinical practice guideline on peri- and postoperative care of arteriovenous fistulas and grafts for haemodialysis in adults
  15. Quality assessment of vascular access procedures for hemodialysis: A position paper of the Vascular Access Society based on the analysis of existing guidelines
  16. The adjuvant treatment of kidney cancer: a multidisciplinary outlook
  17. Antiplatelet therapy for prevention of hemodialysis vascular access thrombosis and improving survival
  18. Osteocalcin (bone GLA protein) levels, vascular calcifications, vertebral fractures and mortality in hemodialysis patients with diabetes mellitus
  19. A Virtual Reality Environment to Visualize Three-Dimensional Patient-Specific Models by a Mobile Head-Mounted Display
  20. Utility of Cardiac Biomarkers in the Setting of Kidney Disease
  21. Patients’ wishes, pregnancy and vascular access: When one size does not fit all
  22. Extracorporeal Removal of Light Chains
  23. Kidney transplantation in patients with previous renal cancer: a critical appraisal of current evidence and guidelines
  24. Cigarette Smoking is Associated with Decreased Bone Gla-protein (BGP) Levels in Hemodialysis Patients
  25. Materials and techniques for percutaneous retrieval of intravascular foreign bodies
  26. Urinary Phosphorus Excretion
  27. Editor's Choice – Vascular Access: 2018 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS)
  28. Clinical relevance and future perspective of fractures in patients with chronic kidney disease
  29. Report of the Standardized Outcomes in Nephrology–Hemodialysis (SONG-HD) Consensus Workshop on Establishing a Core Outcome Measure for Hemodialysis Vascular Access
  30. Authors’ Response to Comments on: The DRIL Procedure for Arteriovenous Access Ischemic Steal: A Controversial Approach
  31. Urinary N-acetyl-β -glucosaminidase and estimated Glomerular filtration rate may identify patients to be treated with immuno-suppression at diagnosis in idiopathic membranous nephropathy
  32. Surgical and Endovascular Intervention for Dialysis Access Maturation Failure During and After Arteriovenous Fistula Surgery: Review of the Evidence
  33. Response to: The role of interventional radiology in detecting abnormalities of the superior vena cava anatomy
  34. Acute Kidney Injury in Cancer Patients
  35. OUP accepted manuscript
  36. Response to: The Role of Ultrasound Evaluation in Central Venous Catheter Exchange
  37. Lupus nephritis and B-cell targeting therapy
  38. Vitamin K plasma levels determination in human health
  39. Erratum to: The vascular access in the elderly: a position statement of the Vascular Access Working Group of the Italian Society of Nephrology
  40. Non-Traditional Aspects of Renal Diets: Focus on Fiber, Alkali and Vitamin K1 Intake
  41. Low vitamin K1 intake in haemodialysis patients
  42. Dialysis access: issues related to conversion from peritoneal dialysis to hemodialysis and vice versa
  43. Response to: Central venous catheterization in fragile patients: which is the best approach?
  44. A Survival Benefit With Phosphate-Binder Treatment in CKD Patients Cannot Be Excluded
  45. Safety of intravenous ferric carboxymaltose versus oral iron in patients with nondialysis-dependent CKD: an analysis of the 1-year FIND-CKD trial
  46. Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial
  47. microscopic hematuria in clinical practice, diagnosis at the point of care
  48. Sudden Death in End Stage Renal Disease: Comparing Hemodialysis versus Peritoneal Dialysis
  49. Vitamin K and bone
  50. DASH and Mediterranean Diets as Nutritional Interventions for CKD Patients
  51. Vitamin K Deficiency in Chronic Kidney Disease: Evidence Is Building Up
  52. Effect of oral anticoagulant therapy on mortality in end-stage renal disease patients with atrial fibrillation: a prospective study
  53. Poor early growth and high salt intake in Indian infants
  54. Management of Hyperphosphatemia
  55. The role of monocytes in ANCA-associated vasculitides
  56. Light chains removal by extracorporeal techniques in acute kidney injury due to multiple myeloma: a position statement of the Onconephrology Work Group of the Italian Society of Nephrology
  57. The DRIL procedure for arteriovenous access ischemic steal: a controversial approach
  58. FAbry STabilization indEX (FASTEX): an innovative tool for the assessment of clinical stabilization in Fabry disease
  59. Echo Color Doppler Ultrasound: A Valuable Diagnostic Tool in the Assessment of Arteriovenous Fistula in Hemodialysis Patients
  60. Haemodialysis Plastic Cannulae - a Possible Alternative to Traditional Metal Needles?
  61. Harmonization of Renal Function Assessment Is Needed Throughout the Whole Process of Anticancer Drug Development
  62. Medicaid Coverage and Access to Care for American Indians and Alaska Natives Under the Affordable Care Act
  63. Adverse Effects of Proton Pump Inhibitors in Chronic Kidney Disease
  64. Renal toxicity of anticancer agents targeting vascular endothelial growth factor (VEGF) and its receptors (VEGFRs)
  65. Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study
  66. Optimization of Dialysis Catheter Function
  67. Training in Dialysis Access - Charting Future Success
  68. The vascular access in the elderly: a position statement of the Vascular Access Working Group of the Italian Society of Nephrology
  69. Diagnostic and prognostic role of myocardial perfusion scintigraphy in kidney transplant candidates: narrative review
  70. Transplantation of kidneys with tumors
  71. Glomerular diseases and cancer: evaluation of underlying malignancy
  72. Grundlagen der Peritonealdialyse
  73. Atrial fibrillation and low vitamin D levels are associated with severe vascular calcifications in hemodialysis patients
  74. Renal toxicity of anticancer agents targeting HER2 and EGFR
  75. Onco-nephrology: a decalogue: Table 1.
  76. Differential Effects of Dabigatran and Warfarin on Bone Volume and Structure in Rats with Normal Renal Function
  77. Renal cancer in kidney transplanted patients
  78. Setting Priorities for Optimizing Vascular Access Decision Making – An International Survey of Patients and Clinicians
  79. Calcimimetic and vitamin D analog use in hemodialyzed patients is associated with increased levels of vitamin K dependent proteins
  80. Aneurysms and pseudoaneurysms in dialysis access
  81. Erratum to: Management of CKD-MBD in non-dialysis patients under regular nephrology care: a prospective multicenter study
  82. Management of CKD-MBD in non-dialysis patients under regular nephrology care: a prospective multicenter study
  83. Prevalence of Vertebral Fractures, Vascular Calcifications, and Mortality in Warfarin Treated Hemodialysis Patients
  84. Mortality, sudden death and indication for cardioverter defibrillator implantation in a dialysis population
  85. Tunneled Central Venous Catheter Exchange: Techniques to Improve Prevention of Air Embolism
  86. Renal effects of targeted anticancer therapies
  87. Retro-aortic, left inferior renal capsular vein
  88. Type of peritoneal dialysis catheter and outcomes
  89. Preferred haemodialysis vascular access for diabetic chronic kidney disease patients: a systematic literature review
  90. Congenital anomalies of superior vena cava and their implications in central venous catheterization
  91. Optimizing vascular access in the elderly: words we use affect patient care
  92. Warfarin use, mortality, bleeding and stroke in haemodialysis patients with atrial fibrillation
  93. Vitamin K and cardiovascular calcification in CKD: is patient supplementation on the horizon?
  94. Cardiovascular complications of calcium supplementation in chronic kidney disease: are there arrhythmic risks?
  95. Drugs in the elderly with chronic kidney disease: beware of potentially inappropriate medications
  96. Fractional excretion of IgG in idiopathic membranous nephropathy with nephrotic syndrome: a predictive marker of risk and drug responsiveness
  97. Evaluation of renal function in elderly patients
  98. The nephrologist’s anticoagulation treatment patterns/regimens in chronic hemodialysis patients with atrial fibrillation
  99. The relationship between the Spine Deformity Index, biochemical parameters of bone metabolism and vascular calcifications: results from the Epidemiological VERtebral FRACtures iTalian Study (EVERFRACT) in dialysis patients
  100. Dialysis central venous catheter types and performance
  101. Fractures in chronic kidney disease: neglected, common, and associated with sickness and death
  102. The Burden of Hypertension and Kidney Disease in Northeast India: The Institute for Indian Mother and Child Noncommunicable Diseases Project
  103. Training and certification in dialysis access
  104. Which cannulation technique for which patient
  105. Reprint of: Vitamin D receptor activation and prevention of arterial ageing
  106. Hypertension and kidney function in an adult population of West Bengal, India: Role of body weight, waist circumference, proteinuria and rural area living
  107. Peritoneal Ultrafiltration in Refractory Heart Failure: A Cohort Study
  108. Anaemia management in non-dialysis chronic kidney disease (CKD) patients: a multicentre prospective study in renal clinics
  109. Percutaneous ultrasound-guided central venous catheters: the lateral in-plane technique for internal jugular vein access
  110. Phosphate control in dialysis
  111. Left ventricular hypertrophy and serum phosphate in peritoneal dialysis patients
  112. Lethal pulmonary thromboembolism: An autopsy-based study on a rare but legally relevant event
  113. Angiotensin II, distal nephron acidification, acid retention, and possibly increased ammonia levels?
  114. Long-Term Proton Pump Inhibitor Use is Associated with Vascular Calcification in Chronic Kidney Disease: A Cross-Sectional Study Using Propensity Score Analysis
  115. High Prevalence of Vertebral Fractures Assessed by Quantitative Morphometry in Hemodialysis Patients, Strongly Associated with Vascular Calcifications
  116. Vitamin K and bone metabolism in the elderly with normal and reduced kidney function
  117. Inequalities in Transplant Waiting List Activation across Italian Dialysis Centers
  118. Peritoneal dialysis access: open versus laparoscopic surgical techniques
  119. Urinary IgG andα2-Macroglobulin Are Powerful Predictors of Outcome and Responsiveness to Steroids and Cyclophosphamide in Idiopathic Focal Segmental Glomerulosclerosis with Nephrotic Syndrome
  120. Prevention of catheter-related blood stream infections (CRBSI)
  121. Virtual Reality: Emerging Role of Simulation Training in Vascular Access
  122. Vitamin K, vertebral fractures, vascular calcifications, and mortality: VItamin K Italian (VIKI) dialysis study
  123. Prevalence and progression of cardiovascular calcifications in peritoneal dialysis patients: A prospective study
  124. The effect of increasing age on the prognosis of non-dialysis patients with chronic kidney disease receiving stable nephrology care
  125. Consequences of Vitamin K2 Deficiency in Hemodialysis Patients
  126. Vitamin D receptor activation and prevention of arterial ageing
  127. Sevelamer for hyperphosphataemia in kidney failure: controversy and perspective
  128. Indications for vascular grafts as hemodialysis access: consensus from experience in Italy
  129. Phosphate Control in Peritoneal Dialysis
  130. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy
  131. Neurological complications of hemodialysis: state of the art
  132. Bleeding, Vertebral Fractures and Vascular Calcifications in Patients Treated with Warfarin: Hope for Lower Risks with Alternative Therapies
  133. Sex and Gender Differences in Nephrology
  134. Clinical signifi cance of FGF-23 measurement in dialysis patients
  135. GLOMERULAR MEMBRANOUS NEPHROPATHY AND WERNER SYNDROME: A CASE REPORT
  136. Effects of vitamin K intake on gamma-carboxylated proteins, bone fractures, and vascular calcifications
  137. Treatment with Calcimimetic (Cinacalcet) Alters Epoetin Dosage Requirements in Dialysis Patients: Preliminary Report
  138. High prevalence of hypertension in normal and underweight Indian children
  139. A Complex Renal Cyst: It Is Time to Call the Oncologist?
  140. Central venous catheters: legal issues
  141. Developing recommendations for vascular access for hemodialysis: Vascular Access Working Group of the Italian Society of Nephrology
  142. Does Systematic Preliminar Colour Doppler Study Reduce Kidney Biopsy Complication Incidence?
  143. Regimen Complexity and Prescription Adherence in Dialysis Patients
  144. Vitamin D Receptor Activators and Clinical Outcomes in Chronic Kidney Disease
  145. Plasma Anti-Xa Monitoring for Low-Molecular-Weight Heparins in Patients with Chronic Kidney Disease
  146. Warfarin and heterotopic ossification: good, bad or ugly?
  147. High-Dose Oral Vitamin D Supplementation and Risk of Falls in Older Women
  148. Diagnosis of acute pyelonephritis by contrast-enhanced ultrasonography in kidney transplant patients
  149. Severe hepatic encephalopathy in a patient with liver cirrhosis after administration of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker combination therapy: a case report
  150. Vertebral fractures in dialysis: Endocrinological disruption of the bone-kidney axis
  151. CCN2 (CTGF) Gene Polymorphism Is a Novel Prognostic Risk Factor for Cardiovascular Outcomes in Hemodialysis Patients
  152. Vascular Calcification and Cardiovascular Outcome in Dialysis Patients: The Role of Gene Polymorphisms
  153. Doppler ultrasound and renal artery stenosis: An overview
  154. Arterial Accelerated Aging in Dialysis Patients: The Clinical Impact of Vascular Calcification
  155. Dialysis Access in Europe and North America: Are We on the Same Path?
  156. Management of Secondary Hyperparathyroidism in the Elderly Patient with Chronic Kidney Disease
  157. Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with mortality in haemodialysis patients
  158. Inflammation and vascular calcification in chronic kidney disease: The role of Fetuin-A
  159. Importance of Vitamin D Receptor Activation in Clinical Practice
  160. New Acquisitions in Therapy of Secondary Hyperparathyroidism in Chronic Kidney Disease and Peritoneal Dialysis Patients: Role of Vitamin D Receptor Activators
  161. Substitution of Calcium Carbonate for Aluminum Hydroxide in Patients on Hemodialysis
  162. Renal outcomes in the ONTARGET study
  163. Role of Hyperphosphatemia on Cardiovascular Disease in Dialysis Patients
  164. Vascular Access in Oncology Patients
  165. Vertebral fractures in patients on dialysis: a clinically relevant problem with insufficient investigation
  166. Low-molecular-weight heparins should be used with caution in patients with chronic kidney disease
  167. Calcium and phosphate: serum levels versus body balance
  168. Pathogenesis and Treatment of Secondary Hyperparathyroidism in Dialysis Patients: The Role of Paricalcitol
  169. Successful use of low-dose intravenous paricalcitol in the treatment of severe secondary hyperparathyroidism in a haemodialysis patient
  170. Preventive Measures and New Pharmacological Approaches of Calcium and Phosphate Disorders
  171. Clinical policies on the management of chronic kidney disease patients in Italy
  172. Machiavelli and urinalysis
  173. Gene Polymorphisms and Serum Alpha-2-Heremans-Schmid Levels in Italian Haemodialysis Patients
  174. Serum Fetuin-A Levels Link Inflammation and Cardiovascular Calcification in Hemodialysis Patients
  175. Decreased serum fetuin-A levels after a single haemodialysis session
  176. Phosphate overload accelerates vascular aging in uremic patients
  177. Role of Hyperphosphatemia on Cardiovascular Disease in Dialysis Patients
  178. Calcium and Phosphate Handling in Peritoneal Dialysis
  179. Vascular Calcification in Uremic Conditions: New Insights into Pathogenesis
  180. Matrix GLA Protein Gene Polymorphisms: Clinical Correlates and Cardiovascular Mortality in Chronic Kidney Disease Patients
  181. Pathogenesis of vascular calcification in chronic kidney disease
  182. Work Ability and Health Status in Dialysis Patients
  183. Regression of uraemic pruritus by cyclosporin treatment in a haemodialysis patient
  184. Hyperparathyroidism and Anemia in Uremic Subjects: A Combined Therapeutic Approach
  185. Severe Cortical and Trabecular Osteopenia in Secondary Hyperparathyroidism
  186. Calcium and Phosphate Plasma Levels in Dialysis Patients after Dietary Ca-P Overload
  187. Captopril-Augmented Renal Scanning
  188. Aspiration Pneumonia
  189. Dynamic of β 2 ‐Microglobulin Fibril Formation and Reabsorption: The Role of Proteolysis
  190. Transient decrease of serum bicarbonate levels with Sevelamer hydrochloride as the phosphate binder
  191. Hyperparathyroidism and Anemia in Renal Failure
  192.  -Interferon-Induced Resistance to 1,25-(OH)2 D3 in Human Monocytes and Macrophages: A Mechanism for the Hypercalcemia of Various Granulomatoses
  193. Trace elements in renal failure: are they clinically important?
  194. Treatment of hyperparathyroidism—why is it crucial to control serum phosphate?
  195. Microtubules Mediate Cellular 25-Hydroxyvitamin D3 Trafficking and the Genomic Response to 1,25-Dihydroxyvitamin D3 in Normal Human Monocytes
  196. Effect of gastric acid secretion on intestinal phosphate and calcium absorption in normal subjects
  197. Recent advances in intravenous calcitriol treatment
  198. Differential catabolism of 22-oxacalcitriol and 1,25-dihydroxyvitamin D3 by normal human peripheral monocytes.
  199. Low-dose intravenous calcitriol treatment of secondary hyperparathyroidism in hemodialysis patients
  200. Desferrioxamine versus erythropoietin for treatment of dialysis anaemia
  201. OVERT DIALYSIS ENCEPHALOPATHY AND MILDLY RAISED PLASMA ALUMINIUM
  202. DIALYSIS AMYLOIDOSIS WITH MASSIVE POPLITEAL DEPOSITION OF β2-MICROGLOBULIN AMYLOID
  203. Aluminum-Dependent Transfusions in Dialysis
  204. What Every Doctor Should Know about Drug Safety in Patients with Chronic Kidney Disease